Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for Cytokine Storm Syndrome in COVID-19
NCT04362111Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Aug 2020
- Primary completion
- Dec 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of anakinra in coronavirus disease 2019 (COVID-19), cytokine release syndrome (CRS), sponsored by University of Alabama at Birmingham. Started Aug 2020; status: completed.
02
Drugs
anakinra
03
Conditions
coronavirus disease 2019 (COVID-19)cytokine release syndrome (CRS)
Beyond the preview
Go deeper on NCT04362111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04362111.